GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA
We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as in glioblastomas that develop from these lower grade lesions. Those tumors without mutations in IDH1 often had mutations at the analogous R17...
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
03.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as in glioblastomas that develop from these lower grade lesions. Those tumors without mutations in IDH1 often had mutations at the analogous R172 residue of the closely related IDH2 gene. These findings have important implications for the pathogenesis and diagnosis of malignant gliomas.
La presente invención se refiere a un polipéptido mutante para usarse en el tratamiento de un tumor de GBM, en donde el polipéptido mutante comprende al menos 8 residuos contiguos de aminoácido de: una proteína de IDH1 humana en un tumor humano, los al menos 8 residuos contiguos de aminoácido que comprenden el residuo 132, en donde el residuo 132 no es arginina; o una proteína de IDH2 humana encontrada en un tumor humano, los a l menos 8 residuos contiguos de aminoácido que comprenden el residuo 172, en donde el residuo 172 no es arginina . |
---|---|
AbstractList | We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as in glioblastomas that develop from these lower grade lesions. Those tumors without mutations in IDH1 often had mutations at the analogous R172 residue of the closely related IDH2 gene. These findings have important implications for the pathogenesis and diagnosis of malignant gliomas.
La presente invención se refiere a un polipéptido mutante para usarse en el tratamiento de un tumor de GBM, en donde el polipéptido mutante comprende al menos 8 residuos contiguos de aminoácido de: una proteína de IDH1 humana en un tumor humano, los al menos 8 residuos contiguos de aminoácido que comprenden el residuo 132, en donde el residuo 132 no es arginina; o una proteína de IDH2 humana encontrada en un tumor humano, los a l menos 8 residuos contiguos de aminoácido que comprenden el residuo 172, en donde el residuo 172 no es arginina . |
Author | Rebecca J. LEARY Victor VELCULESCU Jimmy Cheng-Ho LIN Chien-Tsun KUAN Hai YAN Sian JONES Rachel KARCHIN Nickolas PAPADOPOULOS Xiaosong ZHANG Darell BIGNER Philipp ANGENENDT Giovanni PARMIGIANI D. Williams PARSONS Bert VOGELSTEIN Kenneth W. KINZLER Gregory RIGGINS |
Author_xml | – fullname: Victor VELCULESCU – fullname: Giovanni PARMIGIANI – fullname: Rachel KARCHIN – fullname: Sian JONES – fullname: Kenneth W. KINZLER – fullname: D. Williams PARSONS – fullname: Xiaosong ZHANG – fullname: Rebecca J. LEARY – fullname: Gregory RIGGINS – fullname: Nickolas PAPADOPOULOS – fullname: Bert VOGELSTEIN – fullname: Philipp ANGENENDT – fullname: Hai YAN – fullname: Jimmy Cheng-Ho LIN – fullname: Darell BIGNER – fullname: Chien-Tsun KUAN |
BookMark | eNrjYmDJy89L5WQIdnf1cw3xdFZw9AlxDXIM8fT3C1bw9FPwDPZ39gwBCrgquLh6RLoE-QMVOga7Kjj6uSj4h3i4BimAdILV-jr6eLr7OfqFKLj7ePr7OvIwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknjfCGNTS1NzEydjggoAFmMwhQ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | ALTERACIONES GENETICAS EN ISOCITRATO-DESHIDROGENASA Y OTROS GENES EN GLIOMA MALIGNO. |
ExternalDocumentID | MX359574B |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX359574B3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:13:39 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX359574B3 |
Notes | Application Number: MX20150015733 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181003&DB=EPODOC&CC=MX&NR=359574B |
ParticipantIDs | epo_espacenet_MX359574B |
PublicationCentury | 2000 |
PublicationDate | 20181003 |
PublicationDateYYYYMMDD | 2018-10-03 |
PublicationDate_xml | – month: 10 year: 2018 text: 20181003 day: 03 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | THE JOHNS HOPKINS UNIVERSITY |
RelatedCompanies_xml | – name: THE JOHNS HOPKINS UNIVERSITY |
Score | 3.1726947 |
Snippet | We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181003&DB=EPODOC&locale=&CC=MX&NR=359574B |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANxvsx5YB6q2B9rN2hQl2SrUVrO20FldPUJ-KyTbSIv49TOuCyW-QkVuLEsZP4SwDujBg1SE9zeRCbfVnT455sotsgq0qRDXC_Ese5QCN7ft951p4iPWrB2wYLU78T-lU_jogalaK-V_V6vf47xGJ1bGV5n7wjafU4Ci0mNbtjNFc4SyU2tPg0YAGVKLW8SPJnlsCfGtpwB3bRhzZE7Bd_GQpIyvq_PRkdwd4UWS2rY2jlZQcO6ObbtQ7se81tNyYbxStPYC5CzEKXEnuC_ucP9pe4PnHnAXVDJHDCuPPKZgEWtOec2D4jQejwGRE167KePXHHvu2HZDxxA88-he6Ih9SRsXWLXzksvKjphXoG7eVqmV8A6Rd5L1PVzMCR0AqlMAszUR_SVMmUJNUL_RLOtzC52ppzDYdClHXImnoD7erjM79F01sl3Vps38brg0k |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbjPdj5IB6q4A-tu5Qoa7N1kAf01ZQOU19Ii7bxIr4-zihAy67RXkpceLYTvw5ADe9BDlIzwq5nxhdWdOTe9lAtUFWlTLvo72SJAVHI_tB133WHmM9bsDbGgsj4oR-ieCIyFEZ8nslzuvl3yWWI3wrV7fpO2YtHoaR6Ui1dYziCnep5AxMOg6d0JZs2_RjKZiYHH_a0wZbsI36tcGD7NOXAYekLP_Lk-E-7Iyxq3l1AI1i1YaWvf52rQ27fv3ajcma8VaHMOUuZhGzieWh_vmD_SUsIGwa2izCDEoc6r46kxArWlNKrMAhYeTSCeEtRV3f8tgosIKIjDwW-tYRdIY0sl0ZRzf7pcPMj-tZqMfQnC_mxSmQblnc56qa93AltFIpjdJI1bssU3IlzfRSP4OTDZ2cbyy5hpYb-d7MY8HTBexxsgr3NfUSmtXHZ3GFYrhKO4KE3xdshjk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=GENETIC+ALTERATIONS+IN+ISOCITRATE+DEHYDROGENASE+AND+OTHER+GENES+IN+MALIGNANT+GLIOMA&rft.inventor=Victor+VELCULESCU&rft.inventor=Giovanni+PARMIGIANI&rft.inventor=Rachel+KARCHIN&rft.inventor=Sian+JONES&rft.inventor=Kenneth+W.+KINZLER&rft.inventor=D.+Williams+PARSONS&rft.inventor=Xiaosong+ZHANG&rft.inventor=Rebecca+J.+LEARY&rft.inventor=Gregory+RIGGINS&rft.inventor=Nickolas+PAPADOPOULOS&rft.inventor=Bert+VOGELSTEIN&rft.inventor=Philipp+ANGENENDT&rft.inventor=Hai+YAN&rft.inventor=Jimmy+Cheng-Ho+LIN&rft.inventor=Darell+BIGNER&rft.inventor=Chien-Tsun+KUAN&rft.date=2018-10-03&rft.externalDBID=B&rft.externalDocID=MX359574B |